A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Prelude Therapeutics
Related studies linked through entity extraction aliases.
A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation
- Status
- TERMINATED
- Phase
- PHASE2
A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation
- Status
- TERMINATED
- Phase
- PHASE1
A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation
- Status
- COMPLETED
- Phase
- PHASE1
A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of PRT2527 in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
A Study of PRT1419 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of PRT1419 in Patients With Relapsed/Refractory Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study of PRT811 in Participants With Advanced Solid Tumors, CNS Lymphoma and Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1